issued
on 19 Dec 2023
Last Applicant/ Owned by
3000 Eastpark Boulevard, Suite 300
Cranbury
NJ
08512
Serial Number
97549234 filed on 15th Aug 2022
Registration Number
N/A
Correspondent Address
Michael J. Leonard
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMACEUTICALS INC."
"PHARMACEUTICALS INC." Color is not claimed as a feature of the mark. Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseasesRead More
Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
No 97549234
No Service/Collective Mark
No 186181.00006
No
No
No
No
No
No
No
No
24.17.14 -
Punctuation marks, including commas(,), question marks(?), exclamation points(!¡), ampersands(&), at symbols(@), and hyphens(-)
26.01.01 -
Circles as carriers or as single line borders
The mark consists of a circle with enclosed stylized text of "NVS", followed by text which reads "NOVELSTAR", under which is set forth a text "PHARMACEUTICALS INC."
| Status Date | Action Taken |
|---|---|
| 19th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 24th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 04th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 19th Sep 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 19th Sep 2023 | EXAMINERS AMENDMENT E-MAILED |
| 19th Sep 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 19th Sep 2023 | EXAMINER'S AMENDMENT ENTERED |
| 19th Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th Sep 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
